News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
So pleased (& a little proud) to see U.S. FDA approval of Enzalutamide & Talazoparib in HRR-deficient 1L mCRPC
Photo from Arun Azad/Twitter
Jun 21, 2023, 18:41

So pleased (& a little proud) to see U.S. FDA approval of Enzalutamide & Talazoparib in HRR-deficient 1L mCRPC

In a post by Arun Azad on Twitter, it says, “So pleased (& a little proud) to see U.S. FDA approval of Enzalutamide & Talazoparib in HRR-deficient 1L mCRPC. Impressive rPFS & OS data in this population (see Table). A big win for a lot of pts as approx. 25% of 1L mCRPC pts are HRR-deficient.”

Source: Arun Azad/Twitter

Arun Azad cancer Drugs Enzalutamide Talazoparib U.S. FDA
Special Coverage
Science
Mar 21, 2025, 18:33
Yan Leyfman: Researchers have shed light on a critical aspect of CAR-T therapy - long-term complications
Blog
Mar 21, 2025, 18:26
Applications are open for the M2ICOS project - European School of Oncology
Blog
Mar 21, 2025, 18:19
Douglas Flora: American Cancer Society Cincinnati Golf Classic 2025
Blog
Mar 21, 2025, 18:12
Kim Stanbery: Celebrating our incredible oncology nurses
Blog
Mar 21, 2025, 18:06
Penilla Gunther: Fun to meet different companies in Life Science
Blog
Mar 21, 2025, 18:00
Jordan Rathkopf: Can hospitals use art to challenge, not just comfort?
Blog
Mar 21, 2025, 17:49
Mieke Van Hemelrijck: Our TOUR team will be attending EAU25 in Madrid
Blog
Mar 21, 2025, 17:43
Thomas Hofmarcher: Launch of the 2025 IHE Comparator Report on Cancer in Europe
Science
Mar 21, 2025, 17:36
Pierre Foidart: Patients-related outcomes in OlympiA
Blog
Mar 21, 2025, 17:25
Mila’s story: Overcoming silence and raising awareness for CRC in young adults - Digestive Cancers Europe
Career
Mar 21, 2025, 17:15
Noha Rashad: I have earned the "Certificate of Professional Development in Upper GI Cancers" from ESMO
Blog
Mar 21, 2025, 17:04
Alicia Zhou: Fighting for the future of cancer science amid NIH disruptions